Considering the important role of Prdx2 and Trx1 in hypertrophied heart, therapies aimed at inhibiting Prdx2 and Trx1 are likely to be effective for the prevention of cardiac hypertrophy. The gene discussed is TXN; the disease is cardiac hypertrophy.